Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/53078
Conference/Presentation Title: Cardiac rehabilitation attendance and outcomes 3 years after acute coronary syndrome (ACS): linked national data of the snapshot ACS audit.
Authors: Hyun K.;Hollings M.;Briffa T.;Brieger D.;Chew D.;French J.;Astley C.;Gallagher R.;Ellis C.;Carr B.;Nallaiah K.;Lintern K.;Neubeck L.;Candelaria D.;Redfern J.
Monash Health Department(s): Cardiology (MonashHeart)
Institution: (Hyun, Hollings, Gallagher, Candelaria, Redfern) University of Sydney, Faculty of Medicine and Health, Sydney, Australia
(Briffa) University of Western Australia, School of Population and Global Health, Perth, Australia
(Brieger) Concord Repatriation General Hospital, Department of Cardiology, Sydney, Australia
(Chew) Victorian Heart Hospital, Melbourne, Australia
(French) Liverpool Hospital, Ingham Institute, Univeristy of New South Wales, Sydney, Australia
(Astley) Uniting SA, Adelaide, Australia
(Ellis) Auckland Heart Group, Auckland, New Zealand
(Carr) Agency for Clinical Innovation, Sydney, Australia
(Nallaiah) George Institute for Global Health, Sydney, Australia
(Lintern) Liverpool Hospital, Sydney, Australia
(Neubeck) Edinburgh Napier University, Centre for Cardiovascular Health, Edinburgh, United Kingdom
Presentation/Conference Date: 13-Jan-2025
Copyright year: 2024
Publisher: Oxford University Press
Publication information: European Heart Journal. Conference: European Society of Cardiology Congress, ESC 2024. London United Kingdom. 45(Supplement 1) (no pagination), 2024. Date of Publication: 01 Oct 2024.
Journal: European Heart Journal
Abstract: Background: In international guidelines, cardiac rehabilitation is recommended to reduce readmissions, mortality and improve disease management. However, evidence from a long-term follow-up in a representative cohort is scarce. Purpose(s): To compare 3-year outcomes among acute coronary syndrome (ACS) survivors who attended cardiac rehabilitation programs and those who did not. Method(s): This was a follow-up of the SNAPSHOT ACS cohort in 1,920 Australians. Clinical data of those presenting with suspected ACS, hospitalised, discharged alive and followed for 18 months were linked to jurisdictional/national regulatory hospitalisation, mortality and pharmacotherapy records. Outcomes were all-cause and cardiovascular mortality, myocardial infarction (MI) and cardiovascular readmissions. Cox regression was used to analyse all-cause mortality, and Fine and Gray competing risk model for cardiovascular mortality, MI and cardiovascular readmissions, where non-cardiovascular mortality or all-cause mortality were competing events. The models were adjusted for age, sex, discharge diagnosis and coronary revascularisation. Result(s): The cohort was aged 66+/-13.5 years; 60% were male, 31% had a discharge diagnosis of MI, and 490 (26%) attended cardiac rehabilitation. Cardiac rehabilitation attendees more frequently received coronary revascularisation and had a discharge diagnosis of MI during index admission. Attendees were more likely to be men (70% vs 57%, p<0.001) with a family history of coronary disease (43% vs 36%, p=0.008). The prescription of >=3 guideline-indicated medications was higher in cardiac rehabilitation attendees. Compared to those who did not attend cardiac rehabilitation, the hazard of all-cause mortality was lower for the attendees (4.3% vs 8.6%, HR: 0.55, 95% CI: 0.34-0.91), but the hazard of MI and cardiovascular readmissions significantly greater in the attendees (17% vs 8.5%, HR: 1.99, 95% CI: 1.41-2.82; 42% vs 33%, HR: 1.34, 95% CI: 1.10-1.63; respectively) (Figure). There was insufficient cardiovascular mortality between groups to fit a statistical model (n=7 (1.4%) vs n=24 (1.7%), p=0.705). Conclusion(s): Survivors of ACS attending cardiac rehabilitation were associated with reduced all-cause mortality and increased readmissions related to MI and cardiovascular disease at 3 years follow-up. These findings support secondary prevention strategies to mitigate mortality risk after ACS.
Conference Name: European Society of Cardiology Congress, ESC 2024
Conference Start Date: 2024-08-30
Conference End Date: 2024-09-02
Conference Location: London, United Kingdom
DOI: http://monash.idm.oclc.org/login?url=https://dx.doi.org/10.1093/eurheartj/ehae666.2976
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/53078
Type: Conference Abstract
Subjects: acute coronary syndrome
cardiovascular disease
coronary artery disease
heart infarction
heart muscle revascularization
heart rehabilitation
Type of Clinical Study or Trial: Observational study (cohort, case-control, cross sectional, or survey)
Appears in Collections:Conferences

Show full item record

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.